Bristol-Myers Squibb Looking Higher
BMY | Quote | Chart | News | PowerRating -- Bristol-Myers Squibb Looking Higher
By Mike Paulenoff, www.MPTrader.com
an AdviceTrade.com publication
Earlier this week, Bristol-Myers Squibb emerged to the upside from a two-year base-like accumulation pattern when the price structure hurdled and sustained above 23.80-24.00. Since then (Mon morning), BMY has consolidated above its breakout plateau, which I consider to be a very constructive technical sign—that higher prices should be forthcoming. And based on the magnitude of the base pattern, the potential upside target zones are 25.20/50, then 28.00, and possibly 32-33 thereafter. At this juncture, only a failure to remain above 23.80 will compromise the timing of the anticipated upleg.
For more of Mike Paulenoff, sign up for a Free 15-Day Trial to his ETF Trading Diary. (https://www.mptrader.com/reg/mmm)
mptrader.com
For full details on Bristol-Myers Squibb Co (BMY) BMY. Bristol-Myers Squibb Co (BMY) has Short Term PowerRatings at TradingMarkets. Details on Bristol-Myers Squibb Co (BMY) Short Term PowerRatings is available at This Link.
- Research and Markets: Bristol-Myers Squibb Co. - Company PicShot: All That You Need To Know About a Company in a Comprehensively - 02/09/10
- KineMed broadens collaboration with Bristol-Myers - 02/09/10
- KineMed Broadens Collaboration with Bristol-Myers Squibb - 02/08/10
- BRIEF: Bristol-Myers freezing salaries - 02/06/10
- BRIEF: Worker tied to trade-secrets scheme - 02/05/10
- More News >>


